ESC CONGRESS 2019

31 August - 04 September 2019, Paris - France

Session Details

Poster Session 4: Acute Coronary Syndromes: biomarkers Mon 02 Sep 08:30 - 12:30 European Society of Cardiology Poster Session, Abstract-based Programme Posters - Poster Area Learning Objectives: Posters are on display from 08:30 – 12:30. Presenters will be by their poster during the coffee break from 10:05 and 10:55 for posters viewing time. Other resources List of Presentations Loading... Time   FP Nr   Title   Speakers   Related documents 08:30 P3592 Troponin level and mortality risk in an unselected population of over 250,000 patients (TROP-RISK study) Amit KAURA (London, United Kingdom of Great Britain & Northern Ireland) 08:30 P3593 Improving the performance of high-sensitivity cardiac troponin for the diagnosis of myocardial infarction Atul ANAND (Edinburgh, United Kingdom of Great Britain & Northern Ireland) 08:30 P3594 Transition from 4th to 5th generation cardiac troponin T: testing patterns, myocardial infarction incident rates, and resource utilization across a multicenter United States regional healthcare system Yader SANDOVAL (Minneapolis, United States of America) 08:30 P3595 Risk factors, comorbidities and early dynamic change in high-sensitive cardiac troponin T -The importance of initial troponin level at presentation Victoria MYSDOTTER (Solna, Sweden) 08:30 P3596 The role of MSCT and SPECT in patients with acute coronary syndromes and non-obstructive coronary artery disease. Darya VOROBYEVA (Tomsk, Russian Federation) 08:30 P3597 Occurence of type 2 myocardial infarction in patients with coronary artery disease Melanie JEANMICHEL (Dijon, France) 08:30 P3598 Cardiac Cycle - The effect of exercise on cardiac troponin release Lucy MARSHALL (Edinburgh, United Kingdom of Great Britain & Northern Ireland) 08:30 P3599 Minicare high sensitivity troponin: a novel point-of-care tool to improve ACS workflows Femke DE THEIJE (Eindhoven, Netherlands (The)) 08:30 P3600 High-sensitivity troponin I can predict reduced TIMI coronary grade flow in patients with suspected myocardial infarction Sarina SCHAEFER (Hamburg, Germany)